Susan Hsu – CEO, StatPlus, Taiwan

Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness of the island. Hsu concludes by explaining the service provider’s strategic position within APAC and its unique strength as a globally active, local expert.  
Many Taiwanese companies are too small to enter the global market on their own. In order to be able to attract international partners, more data and evidence is needed to prove the efficacy of their products
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report